## Double-Blind vs. Single-Blind RCTs ### Definition and Core Distinction **Key Point:** In a double-blind RCT, **both participants and investigators** are unaware of treatment allocation. In a single-blind RCT, typically only participants are blinded; investigators know the allocation. ### Comparison Table | Aspect | Single-Blind | Double-Blind | | --- | --- | --- | | **Participant blinding** | Yes | Yes | | **Investigator/provider blinding** | No | Yes | | **Outcome assessor blinding** | Variable | Ideally yes | | **Protection against bias** | Moderate (placebo effect controlled) | Strong (placebo + investigator bias controlled) | | **Feasibility** | Higher | Lower (especially in surgical/behavioral trials) | ### Types of Bias Prevented 1. **Single-blind protects against:** - Placebo effect (participant expectation bias) - Hawthorne effect (behavior change due to awareness of being studied) 2. **Double-blind additionally protects against:** - **Investigator bias** — unconscious differential treatment, assessment, or reporting based on knowledge of allocation - **Confirmation bias** — selective interpretation of findings favoring the hypothesis - **Performance bias** — differential care or attention to treatment vs. control group **High-Yield:** Double-blinding is considered the **gold standard** for RCT design because it controls both participant and investigator sources of bias, maximizing internal validity. **Clinical Pearl:** In some trials (e.g., surgery, psychotherapy), true double-blinding is impossible; in these cases, outcome assessors should be blinded ("assessor-blind" design) to minimize bias in outcome measurement. **Mnemonic:** **Double = Doubt eliminated** — Double-blinding removes doubt from both the participant's mind and the investigator's interpretation.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.